194 related articles for article (PubMed ID: 32457123)
1. Harm Reduction Services in Ottawa: The Culture of Drug Use.
Haines M; O'Byrne P
Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
[TBL] [Abstract][Full Text] [Related]
2. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
Kolla G; Strike C
Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
[TBL] [Abstract][Full Text] [Related]
3. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
[TBL] [Abstract][Full Text] [Related]
4. How understanding and application of drug-related legal instruments affects harm reduction interventions in Cambodia: a qualitative study.
Tuot S; Ngin C; Pal K; Sou S; Sawez G; Morgan P; Srey M; Chan T; Chhoun P; Golichenko O; Choub SC; Yi S
Harm Reduct J; 2017 Jun; 14(1):39. PubMed ID: 28629463
[TBL] [Abstract][Full Text] [Related]
5. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA
Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643
[TBL] [Abstract][Full Text] [Related]
6. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
[TBL] [Abstract][Full Text] [Related]
7. Public support for harm reduction: A population survey of Canadian adults.
Wild TC; Koziel J; Anderson-Baron J; Asbridge M; Belle-Isle L; Dell C; Elliott R; Hathaway A; MacPherson D; McBride K; Pauly B; Strike C; Galovan A; Hyshka E
PLoS One; 2021; 16(5):e0251860. PubMed ID: 34010338
[TBL] [Abstract][Full Text] [Related]
8. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.
McNeil R; Kerr T; Pauly B; Wood E; Small W
Addiction; 2016 Apr; 111(4):685-94. PubMed ID: 26498577
[TBL] [Abstract][Full Text] [Related]
9. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
[TBL] [Abstract][Full Text] [Related]
10. HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service.
Torres-Leguizamon M; Reynaud EG; Néfau T; Duplessy C
Harm Reduct J; 2020 Aug; 17(1):59. PubMed ID: 32831094
[TBL] [Abstract][Full Text] [Related]
11. Research led by people who use drugs: centering the expertise of lived experience.
Salazar ZR; Vincent L; Figgatt MC; Gilbert MK; Dasgupta N
Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):70. PubMed ID: 34544478
[TBL] [Abstract][Full Text] [Related]
12. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis.
Mitra S; Bouck Z; Larney S; Zolopa C; Høj S; Minoyan N; Upham K; Rammohan I; Mok WY; Hayashi K; Milloy MJ; DeBeck K; Scheim A; Werb D
Harm Reduct J; 2024 May; 21(1):94. PubMed ID: 38750575
[TBL] [Abstract][Full Text] [Related]
13. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
Strike C; Watson TM
Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
[TBL] [Abstract][Full Text] [Related]
14. Achieving meaningful participation of people who use drugs and their peer organizations in a strategic research partnership.
Brown G; Crawford S; Perry GE; Byrne J; Dunne J; Reeders D; Corry A; Dicka J; Morgan H; Jones S
Harm Reduct J; 2019 Jun; 16(1):37. PubMed ID: 31182099
[TBL] [Abstract][Full Text] [Related]
15. Navigating the nexus between British Columbia's public consumption and decriminalization policies of illegal drugs.
Ali F; Law J; Russell C; Crépault JF; Goulão JC; Lock K; Rehm J
Health Res Policy Syst; 2024 May; 22(1):60. PubMed ID: 38783308
[TBL] [Abstract][Full Text] [Related]
16. Radical hospitality: Innovative programming to build community and meet the needs of people who use drugs at a government-sanctioned overdose prevention site in San Francisco, California.
Wenger LD; Morris T; Knight KR; Megerian CE; Davidson PJ; Suen LW; Majano V; Lambdin BH; Kral AH
Int J Drug Policy; 2024 Apr; 126():104366. PubMed ID: 38492432
[TBL] [Abstract][Full Text] [Related]
17. Barriers to community-based drug dependence treatment: implications for police roles, collaborations and performance indicators.
Ma Y; Du C; Cai T; Han Q; Yuan H; Luo T; Ren G; Mburu G; Wang B; Golichenko O; Zhang C
J Int AIDS Soc; 2016; 19(4 Suppl 3):20879. PubMed ID: 27435714
[TBL] [Abstract][Full Text] [Related]
18. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
Fischer B; Murphy Y; Rudzinski K; MacPherson D
Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
[TBL] [Abstract][Full Text] [Related]
19. Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk.
Fleming T; Boyd J; Gagnon M; Kerr T; McNeil R
Int J Drug Policy; 2024 Jun; 128():104444. PubMed ID: 38754243
[TBL] [Abstract][Full Text] [Related]
20. Peer worker involvement in low-threshold supervised consumption facilities in the context of an overdose epidemic in Vancouver, Canada.
Kennedy MC; Boyd J; Mayer S; Collins A; Kerr T; McNeil R
Soc Sci Med; 2019 Mar; 225():60-68. PubMed ID: 30798157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
